Head of FMBA Skvortsov: MIR-19 will be effective against the omicron strain
Head of the Federal Medical and Biological Agency (FMBA) Veronika Skvortsova said on the air of the Russia 24 channel that the drug for coronavirus infection MIR-19 will be effective against the omicron strain.
“We looked at 800 lines of different SARS-Cov-2 virus, and that the sequence on which this drug acts, it does not have a single mutation, including in the omicron, “she said.
FMBA received registration for Mir-19 in April 2021. The drug is developed on the basis of microRNA, it is safe for humans and does not affect its genome and immunity, Skvortsova said. She pointed out that the drug turns off the copying of the virus and prevents severe forms of the disease.
The drug can be administered by inhalation or intranasally. It is safe for humans, does not affect its genome and immunity.